<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suggested regimens for therapy of native or prosthetic valve endocarditis due to enterococcal strains susceptible to penicillin and gentamicin*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suggested regimens for therapy of native or prosthetic valve endocarditis due to enterococcal strains susceptible to penicillin and gentamicin*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suggested regimens for therapy of native or prosthetic valve endocarditis due to enterococcal strains susceptible to penicillin and gentamicin*</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2">American Heart Association (AHA)</td> <td class="subtitle1">European Society of Cardiology (ESC)</td> </tr> <tr class="divider_bottom"> <td class="subtitle2">Adult dose</td> <td class="subtitle2">Pediatric dose<sup>¶</sup></td> <td class="subtitle2">Adult dose<sup>Δ</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="2">Aminoglycoside combination regimen<sup>◊</sup></td> <td class="subtitle2_left">Aminoglycoside combination regimen</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <p>Aqueous penicillin G 18 to 30 million units per 24 hours IV continuously or in six divided doses for four to six weeks<sup>§</sup></p> <p><strong>or</strong></p> <p>Ampicillin 2 g IV every 4 hours for four to six weeks<sup>§</sup></p> <p><strong>plus</strong></p> Gentamicin<sup>¥</sup> 3 mg/kg per 24 hours IV or IM in three divided doses for four to six weeks<sup>§</sup> </td> <td> <p>Aqueous penicillin G 200,000 to 300,000 units/kg per 24 hours IV in six divided doses (maximum dose: 24 million units per 24 hours) for four to six weeks<sup>§</sup></p> <p><strong>or</strong></p> <p>Ampicillin 200 to 300 mg/kg per 24 hours IV divided in four or six divided doses (maximum dose: 12 g per 24 hours) for four to six weeks<sup>§</sup></p> <p><strong>plus</strong></p> Gentamicin<sup>¥</sup> 3 to 6 mg/kg per 24 hours IV in two or three divided doses for four to six weeks<sup>§</sup> </td> <td class="indent1"> <p>Amoxicillin 200 mg/kg per 24 hours IV in four or six divided doses for four to six weeks</p> <p><strong>or</strong></p> <p>Ampicillin 12 g per 24 hours (200 mg/kg per 24 hours) IV in four or six divided doses for four to six weeks</p> <p><strong>plus</strong></p> Gentamicin<sup>¥</sup> 3 mg/kg per 24 hours IV or IM in one dose for four to six weeks </td> </tr> <tr> <td class="subtitle2_left" colspan="2">Beta-lactam combination regimen<sup>‡</sup><sup>†</sup></td> <td class="subtitle2_left">Beta-lactam combination regimen<sup>†</sup></td> </tr> <tr> <td class="indent1"> <p>Ceftriaxone 2 g IV every 12 hours for six weeks</p> <p><strong>plus</strong></p> Ampicillin 2 g IV every 4 hours for six weeks </td> <td> <p>Ceftriaxone 100 mg/kg per 24 hours IV in two divided doses or 80 mg/kg in one daily dose (maximum dose: 4 g per 24 hours; if dose is &gt;2 g per 24 hours, use divided dosing every 12 hours) for six weeks</p> <p><strong>plus</strong></p> Ampicillin (dosing as above) for six weeks </td> <td class="indent1"> <p>Ceftriaxone 2 g IV every 12 hours for six weeks</p> <p><strong>plus</strong></p> Ampicillin (dosing as above) for six weeks </td> </tr> </tbody></table></div><div class="graphic_lgnd">The doses in this table are intended for patients with normal renal and hepatic function. The doses of many of these agents must be adjusted in the setting of renal insufficiency; refer to the Lexicomp drug-specific monographs for renal dose adjustments.</div><div class="graphic_footnotes"><p>NVE: native valve endocarditis; PVE: prosthetic valve endocarditis; IV: intravenously; IM: intramuscularly; HLAR: high-level aminoglycoside resistance.</p>
<p>* Patients unable to tolerate beta-lactams should receive treatment as for infection due to isolates with intrinsic penicillin resistance. Refer to UpToDate table on treatment regimens for native or prosthetic valve endocarditis due to an enterococcal strain resistant to penicillin and susceptible to vancomycin and aminoglycosides.</p>
<p>¶ Consultation with an infectious disease specialist is recommended for pediatric patients with enterococcal endocarditis.</p>
<p>Δ Pediatric doses (should not exceed adult doses): amoxicillin 200 mg/kg per 24 hours IV in four to six divided doses; ampicillin 300 mg/kg per 24 hours IV in four or six divided doses; ceftriaxone 100 mg/kg per 24 hours IV or IM in two divided doses; gentamicin 3 mg/kg per 24 hours IV or IM in three divided doses; vancomycin 40 mg/kg per 24 hours IV in two or three divided doses.</p>
<p>◊ Recommended for patients with baseline creatinine clearance &gt;50 mL/min.</p>
<p>§ Patients with NVE and symptoms &lt;3 months may be treated for 4 weeks; patients with PVE or NVE with symptoms ≥3 months should be treated for at least 6 weeks. For adult patients with gentamicin-susceptible isolates, some experts shorten gentamicin component to two weeks when used in combination with a beta-lactam, particularly with emergence of nephrotoxicity (refer to text).</p>
<p>¥ Renal function and gentamicin serum concentrations should be monitored at least once per week. In adults, aminoglycosides are dosed based on ideal body weight. Gentamicin dosage adjusted for peak serum concentrations are 3 to 4 mcg/mL, trough &lt;1 mcg/mL when two to three divided doses used. When given in a single daily dose, pre-dose (trough) concentrations should be &lt;1 mcg/mL. Per ESC guidelines, post-dose (peak, one hour after injection) serum concentrations should be approximately 10 to 12 mcg/mL (per AHA guidelines, there is no role for measuring peak gentamicin concentration following single daily dosing).</p>
<p>‡ Recommended for patients with creatinine clearance ≤50 mL/min (either at baseline or while on therapy with aminoglycoside-containing regimen).</p>
† The beta-lactam combination regimen is active against <em>Enterococcus faecalis</em> strains with and without HLAR and is the combination of choice in patients with HLAR <em>E. faecalis</em> endocarditis; it is not active against <em>Enterococcus faecium</em>. This regimen is reasonable for patients with normal or impaired renal function, abnormal cranial nerve VIII function, or if the laboratory is unable to provide rapid results of aminoglycoside serum concentration.</div><div class="graphic_reference">Data from:
<ol>
<li>Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132:1435.</li>
<li>Baltimore RS, Gewitz M, Baddour LM, et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. Circulation 2015; 132:1487.</li>
<li>Authors/Task Force Members, Habib G, Lancellotti P, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36:3075.</li>
</ol></div><div id="graphicVersion">Graphic 50418 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
